Search Results - "Burgan, William E."

Refine Results
  1. 1

    Inhibition of Hsp90 compromises the DNA damage response to radiation by DOTE, Hideaki, BURGAN, William E, CAMPHAUSEN, Kevin, TOFILON, Philip J

    Published in Cancer research (Chicago, Ill.) (15-09-2006)
    “…Inhibitors of the molecular chaperone Hsp90 have been shown to enhance tumor cell radiosensitivity. To begin to address the mechanism responsible, we have…”
    Get full text
    Journal Article
  2. 2

    In vitro and In vivo Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016 by RUSSO, Andrea L, KWON, Hyuk-Chan, CAMPHAUSEN, Kevin, BURGAN, William E, CARTER, Donna, BEAM, Katie, XU WEIZHENG, JIE ZHANG, SLUSHER, Barbara S, CHAKRAVARTI, Arnab, TOFILON, Philip J

    Published in Clinical cancer research (15-01-2009)
    “…Purpose: Poly (ADP-ribose) polymerase (PARP) inhibitors are undergoing clinical evaluation for cancer therapy. Because PARP inhibition has been shown to…”
    Get full text
    Journal Article
  3. 3

    In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent Temozolomide by WHOON JONG KIL, CERNA, David, BURGAN, William E, BEAM, Katie, CARTER, Donna, STEEG, Patricia S, TOFILON, Philip J, CAMPHAUSEN, Kevin

    Published in Clinical cancer research (01-02-2008)
    “…Purpose: Temozolomide, a DNA methylating agent, is currently undergoing clinical evaluation for cancer therapy. Because temozolomide has been shown to increase…”
    Get full text
    Journal Article
  4. 4

    Postradiation Sensitization of the Histone Deacetylase Inhibitor Valproic Acid by CHINNAIYAN, Prakash, COMA, David, BURGAN, William E, BEAM, Katie, WILLIAMS, Eli S, CAMPHAUSEN, Kevin, TOFILON, Philip J

    Published in Clinical cancer research (01-09-2008)
    “…Purpose: Preclinical studies evaluating histone deacetylase (HDAC) inhibitor-induced radiosensitization have largely focused on the preirradiation setting…”
    Get full text
    Journal Article
  5. 5

    Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid by Camphausen, Kevin, Cerna, David, Scott, Tamalee, Sproull, Mary, Burgan, William E., Cerra, Michael A., Fine, Howard, Tofilon, Philip J.

    Published in International journal of cancer (10-04-2005)
    “…Valproic acid (VA) is a well‐tolerated drug used to treat seizure disorders and has recently been shown to inhibit histone deacetylase (HDAC). Because HDAC…”
    Get full text
    Journal Article
  6. 6

    In vitro and In vivo Radiosensitization with AZD6244 (ARRY-142886), an Inhibitor of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase 1/2 Kinase by EUN JOO CHUNG, BROWN, Aaron P, ASANO, Hiroaki, MANDLER, Mariana, BURGAN, William E, CARTER, Donna, CAMPHAUSEN, Kevin, CITRIN, Deborah

    Published in Clinical cancer research (01-05-2009)
    “…Purpose: The mitogen-activated protein (MAP) kinase pathway is important for cell proliferation, survival, and differentiation, and is frequently up-regulated…”
    Get full text
    Journal Article
  7. 7

    Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts by Baschnagel, Andrew, Russo, Andrea, Burgan, William E, Carter, Donna, Beam, Katie, Palmieri, Diane, Steeg, Patricia S, Tofilon, Philip, Camphausen, Kevin

    Published in Molecular cancer therapeutics (01-06-2009)
    “…Vorinostat (suberoylanilide hydroxamic acid), a histone deacetylase inhibitor, is currently undergoing clinical evaluation as therapy for cancer. We…”
    Get full text
    Journal Article
  8. 8

    Enhancement of In vitro and In vivo Tumor Cell Radiosensitivity by the DNA Methylation Inhibitor Zebularine by DOTE, Hideaki, CERNA, David, BURGAN, William E, CARTER, Donna J, CERRA, Michael A, HOLLINGSHEAD, Melinda G, CAMPHAUSEN, Kevin, TOFILON, Philip J

    Published in Clinical cancer research (15-06-2005)
    “…Aberrant DNA hypermethylation is a frequent finding in tumor cells, which has suggested that inhibition of DNA methylation may be an effective cancer treatment…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells by de la Peña, Lorena, Burgan, William E, Carter, Donna J, Hollingshead, Melinda G, Satyamitra, Merriline, Camphausen, Kevin, Tofilon, Philip J

    Published in Molecular cancer therapeutics (01-06-2006)
    “…Akt has been implicated as a molecular determinant of cellular radiosensitivity. Because it is often constitutively activated or overexpressed in malignant…”
    Get full text
    Journal Article
  11. 11

    In vitro and In vivo Radiosensitization Induced by the Ribonucleotide Reductase Inhibitor Triapine (3-Aminopyridine-2-Carboxaldehyde-Thiosemicarbazone) by Barker, Christopher A, Burgan, William E, Carter, Donna J, Cerna, David, Gius, David, Hollingshead, Melinda G, Camphausen, Kevin, Tofilon, Philip J

    Published in Clinical cancer research (01-05-2006)
    “…Purpose: Because ribonucleotide reductase (RR) plays a role in DNA repair, it may serve as a molecular target for radiosensitization. Unlike previously…”
    Get full text
    Journal Article
  12. 12

    Transcriptional signature of flavopiridol-induced tumor cell death by Lü, Xing, Burgan, William E., Cerra, Michael A., Chuang, Eric Y., Tsai, Mong-Hsun, Tofilon, Philip J., Camphausen, Kevin

    Published in Molecular cancer therapeutics (01-07-2004)
    “…Flavopiridol has been shown to inhibit the proliferation of a variety of human tumor cells and is currently undergoing clinical evaluation in cancer treatment…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102 by Buchanan, Ian M., Scott, Tamalee, Tandle, Anita T., Burgan, William E., Burgess, Teresa L., Tofilon, Philip J., Camphausen, Kevin

    Published in Journal of cellular and molecular medicine (01-09-2011)
    “…The hepatocyte growth factor (HGF)/Met signalling pathway is up‐regulated in many cancers, with downstream mediators playing a role in DNA double strand break…”
    Get full text
    Journal Article
  15. 15

    Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma by Shankavaram, Uma T., Bredel, Markus, Burgan, William E., Carter, Donna, Tofilon, Philip, Camphausen, Kevin

    Published in Journal of cellular and molecular medicine (01-03-2012)
    “…Cell line models have been widely used to investigate glioblastoma multiforme (GBM) pathobiology and in the development of targeted therapies. However, GBM…”
    Get full text
    Journal Article
  16. 16

    Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity by RUSSELL, Jeffery S, BRADY, Kristin, BURGAN, William E, CERRA, Michael A, OSWALD, Kelli A, CAMPHAUSEN, Kevin, TOFILON, Philip J

    Published in Cancer research (Chicago, Ill.) (01-11-2003)
    “…Rad51 is an essential component of the homologous DNA repair pathway and has been implicated as a determinant of cellular radiosensitivity. Gleevec is a…”
    Get full text
    Journal Article
  17. 17

    ErbB3 expression predicts tumor cell radiosensitization induced by Hsp90 inhibition by DOTE, Hideaki, CERNA, David, BURGAN, William E, CAMPHAUSEN, Kevin, TOFILON, Philip J

    Published in Cancer research (Chicago, Ill.) (01-08-2005)
    “…The ability to identify tumors that are susceptible to a given molecularly targeted radiosensitizer would be of clinical benefit. Towards this end, we have…”
    Get full text
    Journal Article
  18. 18

    Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of γH2AX foci by Camphausen, Kevin, Brady, Kristin J., Burgan, William E., Cerra, Michael A., Russell, Jeffery S., Bull, Elizabeth E.A., Tofilon, Philip J.

    Published in Molecular cancer therapeutics (01-04-2004)
    “…Flavopiridol is a cyclin-dependent kinase (CDK) inhibitor, which has recently entered clinical trials. However, when administered as a single agent against…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Abstract A028: An isogenic H/N/KRAS-less mouse embryonic fibroblast cell line panel derived from a size sorted diploid clonal parent by Burgan, William E., Fer, Nicole, Powell, Katie, Xu, Bingfang, Meyer, Mackenzie, Eury, Scott, Neish, Abigail, Soppet, Daniel, Esposito, Dominic, McCormick, Frank, Nissley, Dwight V.

    Published in Molecular cancer research (01-05-2023)
    “…Abstract Shortly after the formation of the NCI Ras Initiative, a H/N/KRAS-less mouse embryonic fibroblast (MEF) cell line panel was generated, validated, and…”
    Get full text
    Journal Article